Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
JAMA Oncology
|
January 6, 2018
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer
Todd A Pezzi, David L Schwartz, Abdallah S R Mohamed, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Veterans Affairs Insurance Disparities for Metastatic Lung Cancer in the Hawaiian Islands
John Q Lin, Shirley Q Li, Todd A Pezzi, et al.
Frontiers in Oncology
|
April 27, 2019
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
Brooke C Bloom, Alexander Augustyn, Todd A Pezzi, et al.
Clinical Lung Cancer
|
May 3, 2025
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer
Abigael Odwuor, Percy Lee, Joe Y Chang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
April 26, 2017
Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer
Chuxiong Ding, Stephen G Chun, Baran D Sumer, et al.
Cancer Investigation
|
November 29, 2016
A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
Stephen G Chun, Randall Hughes, Baran D Sumer, et al.
Cancers
|
November 9, 2024
Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer
Matthew S Ning, Abigael Odwuor, Joe Y Chang, et al.
Clinical Lung Cancer
|
May 25, 2022
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
Steven E Schild, Xiaofei Wang, Christine M Bestvina, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer
Long-Shan Li, Srilakshmi Reddy, Zhen-Hua Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 10, 2022
Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation
Jay P Reddy, Xiudong Lei, Elizabeth S Bloom, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
JAMA Oncology
|
January 6, 2018
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer
Todd A Pezzi, David L Schwartz, Abdallah S R Mohamed, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Veterans Affairs Insurance Disparities for Metastatic Lung Cancer in the Hawaiian Islands
John Q Lin, Shirley Q Li, Todd A Pezzi, et al.
Frontiers in Oncology
|
April 27, 2019
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
Brooke C Bloom, Alexander Augustyn, Todd A Pezzi, et al.
Clinical Lung Cancer
|
May 3, 2025
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer
Abigael Odwuor, Percy Lee, Joe Y Chang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
April 26, 2017
Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer
Chuxiong Ding, Stephen G Chun, Baran D Sumer, et al.
Cancer Investigation
|
November 29, 2016
A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
Stephen G Chun, Randall Hughes, Baran D Sumer, et al.
Cancers
|
November 9, 2024
Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer
Matthew S Ning, Abigael Odwuor, Joe Y Chang, et al.
Clinical Lung Cancer
|
May 25, 2022
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
Steven E Schild, Xiaofei Wang, Christine M Bestvina, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer
Long-Shan Li, Srilakshmi Reddy, Zhen-Hua Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 10, 2022
Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation
Jay P Reddy, Xiudong Lei, Elizabeth S Bloom, et al.
Page
of 8